Bharat Edition

Bharatstox

← All stocks

Vineet Laboratories Ltd.

NSE: VINEETLAB · Healthcare

Sector

Healthcare

Size band

Small cap

Market cap

60cr

ROE

-81.8%

No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.

No guidance on record.

This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Vineet Laboratories Ltd..

No broadcast calls recorded.

We log calls made about a company on business television — Zee Business, CNBC Awaaz and NDTV Profit — as they are stated on air. Nothing is on record for Vineet Laboratories Ltd..

Shareholding

change across 4 filings
CategoryJun 26Mar 26Feb 26Dec 25Change
Promoters6.06.06.012.5−6.5
Foreign institutions0.50.40.00.0+0.5
Domestic institutions0.00.00.00.00.0
Retail & others93.593.794.087.5+6.0

As filed with the exchange for the periods ending Dec 25 to Jun 26.

Filings

latest 25 of 133
  • Clarification - Financial Results8 Sept 2026
    RoutineResults
  • Outcome of Board Meeting25 Aug 2026
    RoutineBoard MeetingFiling PDF ↗
  • Outcome of Board Meeting25 Aug 2026
    RoutineBoard MeetingFiling PDF ↗
  • The Board of Director of the company in its meeting held on August 25 2026 Approved the Audited Standalone Financial Results for the fourth quarter and the financial year ended on 31st ....25 Aug 2026
    RoutineResultsFiling PDF ↗
  • The Board of Directors of the company in its meeting held today i.e., on August 25, 2026 has: Approved the Audited Standalone Financial Results of the Company for the fourth quarter and ....25 Aug 2026
    RoutineBoard MeetingFiling PDF ↗
  • Monitoring Agency Report14 Aug 2026
    Medium impactCredit RatingFiling PDF ↗
  • Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter30 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Certificate under SEBI (Depositories and Participants) Regulations, 201830 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Cessation21 Jul 2026
    Medium impactResignationFiling PDF ↗
  • Change in Director(s)21 Jul 2026
    RoutineGeneralFiling PDF ↗
  • We are hereby informed that Mr. Gaddam Venkata Ramana ( DIN:00031873) has ceased to hold office of Managing Director of Vineet Laboratories with effect form July 21 2026. It further clarified ....21 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Appointment of Rajesh Kumar Kathulla as an Additional Director (Executive Catagory) of the company with effect from 11th day of June, 202621 Jul 2026
    Medium impactAppointmentFiling PDF ↗
  • General Updates16 Jul 2026
    RoutineBoard MeetingFiling PDF ↗
  • Disclosure under SEBI Takeover Regulations24 Jun 2026
    High impactM&AFiling PDF ↗
  • Resignation29 May 2026
    Medium impactResignationFiling PDF ↗
  • Monitoring Agency Report15 May 2026
    Medium impactCredit RatingFiling PDF ↗
  • Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter29 Apr 2026
    RoutineGeneralFiling PDF ↗
  • Structural Digital Database21 Apr 2026
    RoutineGeneralFiling PDF ↗
  • Certificate under SEBI (Depositories and Participants) Regulations, 201821 Apr 2026
    RoutineGeneralFiling PDF ↗
  • Trading Window30 Mar 2026
    Medium impactInsider TradingFiling PDF ↗
  • Copy of Newspaper Publication16 Feb 2026
    RoutineResultsFiling PDF ↗
  • General Updates4 Feb 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication4 Feb 2026
    RoutineGeneralFiling PDF ↗
  • Committee Meeting Updates2 Feb 2026
    RoutineBoard MeetingFiling PDF ↗
  • Copy of Newspaper Publication14 Jan 2026
    RoutineGeneralFiling PDF ↗

The 25 most recent of 133 filings we hold for VINEETLAB, back to January 2024. Every filing, by day.

Disclaimer

Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.

Bharat ke stocks, har subah.

One daily brief on what India's SEBI-registered research analysts are calling. No noise, no spam, unsubscribe whenever.